Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premenopause | 1 | 2015 | 30 | 0.480 |
Why?
|
| Adnexal Diseases | 1 | 2015 | 23 | 0.470 |
Why?
|
| Genital Neoplasms, Female | 3 | 2018 | 46 | 0.380 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1460 | 0.280 |
Why?
|
| Referral and Consultation | 2 | 2015 | 540 | 0.180 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 97 | 0.160 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2017 | 10 | 0.160 |
Why?
|
| Brachytherapy | 1 | 2018 | 75 | 0.150 |
Why?
|
| Salpingo-oophorectomy | 1 | 2017 | 10 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 36 | 0.140 |
Why?
|
| Omentum | 1 | 2017 | 47 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 330 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 408 | 0.120 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 2 | 0.110 |
Why?
|
| Thiadiazoles | 1 | 2014 | 5 | 0.110 |
Why?
|
| Health Status Indicators | 1 | 2014 | 120 | 0.110 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2015 | 63 | 0.110 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 61 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 66 | 0.110 |
Why?
|
| Gynecology | 1 | 2015 | 123 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2014 | 173 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2015 | 215 | 0.110 |
Why?
|
| Hysterectomy | 1 | 2014 | 192 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 107 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 286 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 383 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 546 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2015 | 928 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2824 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 998 | 0.070 |
Why?
|
| Aged | 6 | 2020 | 19460 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3576 | 0.050 |
Why?
|
| Female | 7 | 2020 | 66264 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 3062 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1127 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6467 | 0.050 |
Why?
|
| SEER Program | 1 | 2020 | 199 | 0.040 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 14 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 62 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 4730 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2018 | 16223 | 0.040 |
Why?
|
| Humans | 7 | 2020 | 124326 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2017 | 44 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 42 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 51 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 68 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 46 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 422 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 26442 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2017 | 71 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 1218 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 117 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 29378 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2020 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 75 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 662 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 152 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1237 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1064 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 588 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 887 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1417 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1804 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1322 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3342 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4554 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 3371 | 0.020 |
Why?
|
| United States | 1 | 2020 | 10766 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2507 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 5807 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10139 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4532 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 8978 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12279 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17723 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 34134 | 0.010 |
Why?
|